Search results
Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
Zacks via Yahoo News· 1 week agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Judge gives split ruling in Covid-19 vaccine patent legal battle
PA Media: UK News via Yahoo News· 2 weeks agoA legal battle between rival developers of Covid-19 jabs over life-saving vaccine technology patents...
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Zacks via Yahoo News· 2 weeks agoPfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal...
FDA Approves Pfizer, Moderna's Omicron COVID Jabs in Younger Kids
Zacks via Yahoo News· 2 years agoAmid a rise in seasonal respiratory illnesses in younger children across the country, the FDA...
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 2 months agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
BioNTech (BNTX) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo News· 2 years agoOn BioNTech's (BNTX) third-quarter earnings call, investors will likely focus on the sales...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo News· 2 months agoPfizer PFE reported first-quarter 2024 adjusted earnings per share of 82 cents, which comfortably...
Pfizer (PFE) Q1 Earnings Beat, COVID Jab Sales Down as Expected
Zacks via Yahoo News· 1 year agoPfizer PFE reported first-quarter 2023 adjusted earnings per share of $1.23, which beat the Zacks...
Pfizer (PFE) Q4 Earnings Top, Revenues Miss on COVID Sales Slump
Zacks via Yahoo News· 5 months agoPfizer PFE reported fourth-quarter 2023 adjusted earnings per share of 10 cents in contrast to the...
Pfizer's (PFE) Q3 Loss Narrows, Sales Miss on COVID Slump
Zacks via Yahoo News· 8 months agoPfizer PFE reported third-quarter 2023 adjusted loss per share of 17 cents, which was narrower than...